207 related articles for article (PubMed ID: 31109130)
1. Norcantharidin Suppresses YD-15 Cell Invasion Through Inhibition of FAK/Paxillin and F-Actin Reorganization.
Hong KO; Ahn CH; Yang IH; Han JM; Shin JA; Cho SD; Hong SD
Molecules; 2019 May; 24(10):. PubMed ID: 31109130
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.
Wang H; Sun W; Zhang WZ; Ge CY; Zhang JT; Liu ZY; Fan YZ
PLoS One; 2014; 9(5):e96982. PubMed ID: 24811250
[TBL] [Abstract][Full Text] [Related]
3. Antimetastatic effects of norcantharidin on hepatocellular carcinoma by transcriptional inhibition of MMP-9 through modulation of NF-kB activity.
Yeh CB; Hsieh MJ; Hsieh YH; Chien MH; Chiou HL; Yang SF
PLoS One; 2012; 7(2):e31055. PubMed ID: 22363545
[TBL] [Abstract][Full Text] [Related]
4. Norcantharidin modulates the miR-30a/Metadherin/AKT signaling axis to suppress proliferation and metastasis of stromal tumor cells in giant cell tumor of bone.
Chen F; Wang S; Wei Y; Wu J; Huang G; Chen J; Shi J; Xia J
Biomed Pharmacother; 2018 Jul; 103():1092-1100. PubMed ID: 29710674
[TBL] [Abstract][Full Text] [Related]
5. Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway.
Zhang JT; Sun W; Zhang WZ; Ge CY; Liu ZY; Zhao ZM; Lu XS; Fan YZ
BMC Cancer; 2014 Mar; 14():193. PubMed ID: 24628713
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of norcantharidin, a derivative compound from blister beetles, on tumor invasion and metastasis in CT26 colorectal adenocarcinoma cells.
Chen YJ; Shieh CJ; Tsai TH; Kuo CD; Ho LT; Liu TY; Liao HF
Anticancer Drugs; 2005 Mar; 16(3):293-9. PubMed ID: 15711181
[TBL] [Abstract][Full Text] [Related]
7. Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway.
Fan T; Chen J; Zhang L; Gao P; Hui Y; Xu P; Zhang X; Liu H
Mol Cancer; 2016 Mar; 15():23. PubMed ID: 26956728
[TBL] [Abstract][Full Text] [Related]
8. Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of WIF-1 in glioma.
Xie D; Xie J; Wan Y; Ma L; Qi X; Wang K; Yang S
Oncol Rep; 2016 Apr; 35(4):2191-7. PubMed ID: 26781164
[TBL] [Abstract][Full Text] [Related]
9. Diallyl trisulfide inhibits cell migration and invasion of human melanoma a375 cells via inhibiting integrin/facal adhesion kinase pathway.
Wang HC; Chu YL; Hsieh SC; Sheen LY
Environ Toxicol; 2017 Nov; 32(11):2352-2359. PubMed ID: 28741790
[TBL] [Abstract][Full Text] [Related]
10. Norcantharidin inhibits proliferation and promotes apoptosis via c-Met/Akt/mTOR pathway in human osteosarcoma cells.
Mei L; Sang W; Cui K; Zhang Y; Chen F; Li X
Cancer Sci; 2019 Feb; 110(2):582-595. PubMed ID: 30520540
[TBL] [Abstract][Full Text] [Related]
11. A small-molecule metastasis inhibitor, norcantharidin, downregulates matrix metalloproteinase-9 expression by inhibiting Sp1 transcriptional activity in colorectal cancer cells.
Chen YJ; Chang WM; Liu YW; Lee CY; Jang YH; Kuo CD; Liao HF
Chem Biol Interact; 2009 Oct; 181(3):440-6. PubMed ID: 19616522
[TBL] [Abstract][Full Text] [Related]
12. Norcantharidin inhibits IL-6-induced epithelial‑mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells.
Gao Y; Li W; Liu R; Guo Q; Li J; Bao Y; Zheng H; Jiang S; Hua B
Oncol Rep; 2017 Aug; 38(2):1224-1232. PubMed ID: 28677802
[TBL] [Abstract][Full Text] [Related]
13. Contribution of p38 MAPK Pathway to Norcantharidin-Induced Programmed Cell Death in Human Oral Squamous Cell Carcinoma.
Ahn CH; Hong KO; Jin B; Lee W; Jung YC; Lee H; Shin JA; Cho SD; Hong SD
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31315217
[TBL] [Abstract][Full Text] [Related]
14. Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells.
Chen YJ; Kuo CD; Tsai YM; Yu CC; Wang GS; Liao HF
Anticancer Drugs; 2008 Jan; 19(1):55-64. PubMed ID: 18043130
[TBL] [Abstract][Full Text] [Related]
15. Norcantharidin Suppresses Colon Cancer Cell Epithelial-Mesenchymal Transition by Inhibiting the αvβ6-ERK-Ets1 Signaling Pathway.
Peng C; Li Z; Niu Z; Niu W; Xu Z; Gao H; Niu W; Wang J; He Z; Gao C; Lin P; Agrez M; Zhang Z; Niu J
Sci Rep; 2016 Feb; 6():20500. PubMed ID: 26846153
[TBL] [Abstract][Full Text] [Related]
16. Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen-integrin α
Hsia CH; Lu WJ; Lin KH; Chou DS; Geraldine P; Jayakuma T; Chang NC; Sheu JR
J Cell Mol Med; 2018 Apr; 22(4):2142-2152. PubMed ID: 29369482
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro.
Fan YZ; Fu JY; Zhao ZM; Chen CQ
Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):72-80. PubMed ID: 17287171
[TBL] [Abstract][Full Text] [Related]
18. Salinomycin attenuates liver cancer stem cell motility by enhancing cell stiffness and increasing F-actin formation via the FAK-ERK1/2 signalling pathway.
Sun J; Luo Q; Liu L; Yang X; Zhu S; Song G
Toxicology; 2017 Jun; 384():1-10. PubMed ID: 28395993
[TBL] [Abstract][Full Text] [Related]
19. [The in vitro effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells and its mechanism].
Fan YZ; Fu JY; Zhao ZM; Chen CQ
Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):271-4. PubMed ID: 15312360
[TBL] [Abstract][Full Text] [Related]
20. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]